Literature DB >> 28793257

The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons.

Hidekuni Yamakawa1, Jemmie Cheng1, Jay Penney1, Fan Gao1, Richard Rueda1, Jun Wang1, Satoko Yamakawa1, Oleg Kritskiy1, Elizabeta Gjoneska1, Li-Huei Tsai2.   

Abstract

The histone deacetylase HDAC2, which negatively regulates synaptic gene expression and neuronal plasticity, is upregulated in Alzheimer's disease (AD) patients and mouse models. Therapeutics targeting HDAC2 hold promise for ameliorating AD-related cognitive impairment; however, attempts to generate HDAC2-specific inhibitors have failed. Here, we take an integrative genomics approach to identify proteins that mediate HDAC2 recruitment to synaptic plasticity genes. Functional screening revealed that knockdown of the transcription factor Sp3 phenocopied HDAC2 knockdown and that Sp3 facilitated recruitment of HDAC2 to synaptic genes. Importantly, like HDAC2, Sp3 expression was elevated in AD patients and mouse models, where Sp3 knockdown ameliorated synaptic dysfunction. Furthermore, exogenous expression of an HDAC2 fragment containing the Sp3-binding domain restored synaptic plasticity and memory in a mouse model with severe neurodegeneration. Our findings indicate that targeting the HDAC2-Sp3 complex could enhance cognitive function without affecting HDAC2 function in other processes.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; epigenetic; histone acetylation; memory; synaptic plasticity

Mesh:

Substances:

Year:  2017        PMID: 28793257     DOI: 10.1016/j.celrep.2017.07.044

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  28 in total

Review 1.  Regulation of Central Nervous System Development by Class I Histone Deacetylases.

Authors:  Santosh R D'Mello
Journal:  Dev Neurosci       Date:  2020-01-24       Impact factor: 2.984

2.  PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia.

Authors:  Tonya M Gilbert; Nicole R Zürcher; Christine J Wu; Anisha Bhanot; Baileigh G Hightower; Minhae Kim; Daniel S Albrecht; Hsiao-Ying Wey; Frederick A Schroeder; Anais Rodriguez-Thompson; Thomas M Morin; Kamber L Hart; Amelia M Pellegrini; Misha M Riley; Changning Wang; Steven M Stufflebeam; Stephen J Haggarty; Daphne J Holt; Marco L Loggia; Roy H Perlis; Hannah E Brown; Joshua L Roffman; Jacob M Hooker
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

3.  Setbacks and promises for drugs against Alzheimer's disease: As pharmaceutical companies are retreating from drug development for Alzheimer's, new approaches are being tested in academia and biotech companies.

Authors:  Andrea Rinaldi
Journal:  EMBO Rep       Date:  2018-08-27       Impact factor: 8.807

4.  Hippocampal gene expression patterns linked to late-life physical activity oppose age and AD-related transcriptional decline.

Authors:  Nicole C Berchtold; G Aleph Prieto; Michael Phelan; Daniel L Gillen; Pierre Baldi; David A Bennett; Aron S Buchman; Carl W Cotman
Journal:  Neurobiol Aging       Date:  2019-02-20       Impact factor: 4.673

5.  Lactate Mediates the Effects of Exercise on Learning and Memory through SIRT1-Dependent Activation of Hippocampal Brain-Derived Neurotrophic Factor (BDNF).

Authors:  Lauretta El Hayek; Mohamad Khalifeh; Victor Zibara; Rawad Abi Assaad; Nancy Emmanuel; Nabil Karnib; Rim El-Ghandour; Patrick Nasrallah; Maria Bilen; Pascale Ibrahim; Joe Younes; Edwina Abou Haidar; Nour Barmo; Vanessa Jabre; Joseph S Stephan; Sama F Sleiman
Journal:  J Neurosci       Date:  2019-01-28       Impact factor: 6.167

6.  Sp1 in Astrocyte Is Important for Neurite Outgrowth and Synaptogenesis.

Authors:  Chia-Yang Hung; Tsung-I Hsu; Jian-Ying Chuang; Tsung-Ping Su; Wen-Chang Chang; Jan-Jong Hung
Journal:  Mol Neurobiol       Date:  2019-07-18       Impact factor: 5.590

7.  [11C]Martinostat PET analysis reveals reduced HDAC I availability in Alzheimer's disease.

Authors:  Tharick A Pascoal; Mira Chamoun; Elad Lax; Hsiao-Ying Wey; Monica Shin; Kok Pin Ng; Min Su Kang; Sulantha Mathotaarachchi; Andrea L Benedet; Joseph Therriault; Firoza Z Lussier; Frederick A Schroeder; Jonathan M DuBois; Baileigh G Hightower; Tonya M Gilbert; Nicole R Zürcher; Changning Wang; Robert Hopewell; Mallar Chakravarty; Melissa Savard; Emilie Thomas; Sara Mohaddes; Sarah Farzin; Alyssa Salaciak; Stephanie Tullo; A Claudio Cuello; Jean-Paul Soucy; Gassan Massarweh; Heungsun Hwang; Eliane Kobayashi; Bradley T Hyman; Bradford C Dickerson; Marie-Christine Guiot; Moshe Szyf; Serge Gauthier; Jacob M Hooker; Pedro Rosa-Neto
Journal:  Nat Commun       Date:  2022-07-19       Impact factor: 17.694

8.  A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway.

Authors:  Ying Han; Le Chen; Jingyun Liu; Jie Chen; Chunyang Wang; Yu Guo; Xuebin Yu; Chenghong Zhang; Haiying Chu; Haiying Ma
Journal:  Molecules       Date:  2022-06-29       Impact factor: 4.927

9.  Identification of risk genes for Alzheimer's disease by gene embedding.

Authors:  Yashwanth Lagisetty; Thomas Bourquard; Ismael Al-Ramahi; Carl Grant Mangleburg; Samantha Mota; Shirin Soleimani; Joshua M Shulman; Juan Botas; Kwanghyuk Lee; Olivier Lichtarge
Journal:  Cell Genom       Date:  2022-07-26

10.  Valproate reverses mania-like behaviors in mice via preferential targeting of HDAC2.

Authors:  Ryan W Logan; Angela R Ozburn; Rachel N Arey; Kyle D Ketchesin; Alicia Winquist; Andrew Crain; Brian T D Tobe; Darius Becker-Krail; Matthew B Jarpe; Xiangning Xue; Wei Zong; Zhiguang Huo; Puja K Parekh; Xiyu Zhu; Ethan Fitzgerald; Hui Zhang; Jeffrey Oliver-Smith; Lauren M DePoy; Mariah A Hildebrand; Evan Y Snyder; George C Tseng; Colleen A McClung
Journal:  Mol Psychiatry       Date:  2020-11-24       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.